Non-invasive tests to track chronic liver disease
Part of Digestive system clinical trials.
This study is looking for a better way to diagnose and track chronic liver disease without invasive procedures like biopsies. If you join, researchers will use simple tests (like blood tests or imaging) to see how well they predict the progression of your liver condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must either have a confirmed liver disease (from a biopsy or doctor's diagnosis), be undergoing a biopsy for suspected liver disease, have signs of cirrhosis, or have conditions like diabetes or obesity that increase your risk for liver disease.
- You cannot be pregnant.
- You cannot have an active cancer.
- You must be expected to live at least 5 more years.
- You must be able and willing to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well noninvasive tests (tests that don’t require surgery, like scans and blood-based measurements) can diagnose chronic liver disease in people with certain liver conditions. It may help doctors choose better, less invasive ways to identify the type and stage of liver problems.
This study tests a new device called Hepatoscope that measures your liver health without a needle. It may be a good option if you have liver problems, diabetes, or metabolic syndrome and want a simple, noninvasive check.
This study looks at people with advanced chronic liver disease to find ways to predict when they might get worse or develop liver cancer. Researchers hope to use this information to prevent complications and improve care.
This study looks at new, non-invasive methods to predict when chronic liver disease might get worse. It could help you and your doctor catch problems early without needing a biopsy or other invasive procedures.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
This study looks at how blood clotting, inflammation, and blood vessels change in people with chronic liver disease or cirrhosis. Your blood tests may help researchers understand what drives the disease and could guide future care.
Hear when a new Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.